Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039656885> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W3039656885 endingPage "e315" @default.
- W3039656885 startingPage "e310" @default.
- W3039656885 abstract "Psoriasis is a multifactorial chronic inflammatory skin disease characterized by erythemato-squamous lesions with a chronic relapsing course. The desease clinical activity (PASI) and the patient's quality of life (DLQI) are the main elements to assess for setting up a correct therapeutic management.The aim of the study was to evaluate the management of the patient with moderate-severe psoriasis in therapy with biological drugs and to establish the difference in the achievement of PASI 90 and DLQI 0-1 between a group of patients treated with only biological drugs and a group of patients receiving biologic therapy in combination with a topical ointment.We conducted a prospective, observational real-life study enrolling 60 patients with moderate to severe psoriasis and divided in two groups: Group A patients treated with biological drugs, Group B patiens treated with biological drugs in association with an ointment composed of betamethasone, salicylic acid and ammonium sulpho-ichtyolate, applied 2 times a day. PASI and DLQI were evaluated at study beginning (T0) for both study groups, after 12 weeks (T3) for sample in therapy with biological drugs and after 24 weeks (T6) for sample in co-medication therapy.The two-way ANOVA method was used to evaluate the standard deviations (SD): at T3 and T6 Group B obtained a significant PASI reduction and improvement of DLQI (* p value <0.05) compared to Group A.Our study shown that the patients treated with biologics in co-medication with topical therapy reached a significantly higher PASI and DQLI compared with those treated with only biologics. Furthermore we observed that the association with topical oinment showed more efficacy in the treatment of areas such as palm-plantar region, that is often difficult-to-treat region, even for biologic drugs." @default.
- W3039656885 created "2020-07-10" @default.
- W3039656885 creator A5000743921 @default.
- W3039656885 creator A5012345302 @default.
- W3039656885 creator A5023698033 @default.
- W3039656885 creator A5029517167 @default.
- W3039656885 creator A5036093206 @default.
- W3039656885 creator A5053492151 @default.
- W3039656885 creator A5061264963 @default.
- W3039656885 creator A5064383618 @default.
- W3039656885 creator A5068250676 @default.
- W3039656885 creator A5073037841 @default.
- W3039656885 creator A5081844213 @default.
- W3039656885 date "2020-07-03" @default.
- W3039656885 modified "2023-09-23" @default.
- W3039656885 title "Benefit of a topic ointment as co-medication with biologic drugs for the management of moderate-severe psoriasis: a prospective, observational real-life study." @default.
- W3039656885 doi "https://doi.org/10.7417/ct.2020.2234" @default.
- W3039656885 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32614366" @default.
- W3039656885 hasPublicationYear "2020" @default.
- W3039656885 type Work @default.
- W3039656885 sameAs 3039656885 @default.
- W3039656885 citedByCount "3" @default.
- W3039656885 countsByYear W30396568852022 @default.
- W3039656885 crossrefType "journal-article" @default.
- W3039656885 hasAuthorship W3039656885A5000743921 @default.
- W3039656885 hasAuthorship W3039656885A5012345302 @default.
- W3039656885 hasAuthorship W3039656885A5023698033 @default.
- W3039656885 hasAuthorship W3039656885A5029517167 @default.
- W3039656885 hasAuthorship W3039656885A5036093206 @default.
- W3039656885 hasAuthorship W3039656885A5053492151 @default.
- W3039656885 hasAuthorship W3039656885A5061264963 @default.
- W3039656885 hasAuthorship W3039656885A5064383618 @default.
- W3039656885 hasAuthorship W3039656885A5068250676 @default.
- W3039656885 hasAuthorship W3039656885A5073037841 @default.
- W3039656885 hasAuthorship W3039656885A5081844213 @default.
- W3039656885 hasConcept C126322002 @default.
- W3039656885 hasConcept C159110408 @default.
- W3039656885 hasConcept C16005928 @default.
- W3039656885 hasConcept C188816634 @default.
- W3039656885 hasConcept C23131810 @default.
- W3039656885 hasConcept C2779951463 @default.
- W3039656885 hasConcept C2780564577 @default.
- W3039656885 hasConcept C2781162121 @default.
- W3039656885 hasConcept C500440147 @default.
- W3039656885 hasConcept C71924100 @default.
- W3039656885 hasConceptScore W3039656885C126322002 @default.
- W3039656885 hasConceptScore W3039656885C159110408 @default.
- W3039656885 hasConceptScore W3039656885C16005928 @default.
- W3039656885 hasConceptScore W3039656885C188816634 @default.
- W3039656885 hasConceptScore W3039656885C23131810 @default.
- W3039656885 hasConceptScore W3039656885C2779951463 @default.
- W3039656885 hasConceptScore W3039656885C2780564577 @default.
- W3039656885 hasConceptScore W3039656885C2781162121 @default.
- W3039656885 hasConceptScore W3039656885C500440147 @default.
- W3039656885 hasConceptScore W3039656885C71924100 @default.
- W3039656885 hasIssue "4" @default.
- W3039656885 hasLocation W30396568851 @default.
- W3039656885 hasOpenAccess W3039656885 @default.
- W3039656885 hasPrimaryLocation W30396568851 @default.
- W3039656885 hasRelatedWork W1978428707 @default.
- W3039656885 hasRelatedWork W2056256840 @default.
- W3039656885 hasRelatedWork W2161648634 @default.
- W3039656885 hasRelatedWork W2196473240 @default.
- W3039656885 hasRelatedWork W2461170543 @default.
- W3039656885 hasRelatedWork W2766413417 @default.
- W3039656885 hasRelatedWork W2923741572 @default.
- W3039656885 hasRelatedWork W3084498249 @default.
- W3039656885 hasRelatedWork W4245009736 @default.
- W3039656885 hasRelatedWork W4252495384 @default.
- W3039656885 hasVolume "171" @default.
- W3039656885 isParatext "false" @default.
- W3039656885 isRetracted "false" @default.
- W3039656885 magId "3039656885" @default.
- W3039656885 workType "article" @default.